These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21787159)

  • 61. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy.
    Fujimori A; Naito H; Miyazaki T
    Artif Organs; 1998 Dec; 22(12):1014-7. PubMed ID: 9876092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of chemical germicides on the integrity of hemodialyzer membranes.
    Bland LA; Favero MS; Oxborrow GS; Aguero SM; Searcy BP; Danielson JW
    ASAIO Trans; 1988; 34(3):172-5. PubMed ID: 3058170
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biocompatibility differences with respect to the dialyzer sterilization method.
    Müller TF; Seitz M; Eckle I; Lange H; Kolb G
    Nephron; 1998; 78(2):139-42. PubMed ID: 9496728
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low-flux versus high-flux synthetic dialysis membrane in acute renal failure: prospective randomized study.
    Ponikvar JB; Rus RR; Kenda RB; Bren AF; Ponikvar RR
    Artif Organs; 2001 Dec; 25(12):946-50. PubMed ID: 11843761
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of dialyzer membranes on mortality in uremic patients undergoing long-term hemodialysis: A Nationwide population-based study using the Taiwan Dialysis Registry Data System 2005-2012.
    Chang CY; Wu MS; Chang CH; Lin CC; Lin HL; Kao CC; Chen HH; Li A; Hsu CC; Lin YC
    Ther Apher Dial; 2022 Feb; 26(1):55-63. PubMed ID: 33928757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of vitamin E-modified polysulfone membrane dialyzers.
    Sasaki M
    J Artif Organs; 2006; 9(1):50-60. PubMed ID: 16614802
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Complement activation by dialysis membranes and its association with secondary membrane formation and surface charge.
    Melchior P; Erlenkötter A; Zawada AM; Delinski D; Schall C; Stauss-Grabo M; Kennedy JP
    Artif Organs; 2021 Jul; 45(7):770-778. PubMed ID: 33326619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transport Characteristics of Asymmetric Cellulose Triacetate Hemodialysis Membranes.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Blood Purif; 2018; 45(1-3):46-52. PubMed ID: 29161718
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial.
    Ehlerding G; Erlenkötter A; Gauly A; Griesshaber B; Kennedy J; Rauber L; Ries W; Schmidt-Gürtler H; Stauss-Grabo M; Wagner S; Zawada AM; Zschätzsch S; Kempkes-Koch M
    Kidney360; 2021 Jun; 2(6):937-947. PubMed ID: 35373083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Difference in beta 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers.
    Mineshima M; Hoshino T; Era K; Kitano Y; Suzuki T; Sanaka T; Teraoka S; Agishi T; Ota K
    ASAIO Trans; 1990; 36(3):M643-6. PubMed ID: 2252773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of endotoxin antibody in long-term dialysis patients.
    Yamagami S; Adachi T; Sugimura T; Wada S; Kishimoto T; Maekawa M; Yoshimura R; Niwa M; Terano Y; Shaldon S
    Int J Artif Organs; 1990 Apr; 13(4):205-10. PubMed ID: 2115504
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis.
    Clark WR; Hamburger RJ; Lysaght MJ
    Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dilemma of membrane biocompatibility and reuse.
    Klinkmann H; Grassmann A; Vienken J
    Artif Organs; 1996 May; 20(5):426-32. PubMed ID: 8725623
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dialyzer reuse following manual reprocessing with a new sterilant, RenNew-D.
    Gagnon R; Adkar V; Kaye M
    Artif Organs; 1987 Apr; 11(2):132-6. PubMed ID: 3593042
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biocompatibility of high-flux membranes.
    Putz D; Barnas U; Luger A; Mayer G; Woloszczuk W; Graf H
    Int J Artif Organs; 1992 Aug; 15(8):456-60. PubMed ID: 1399092
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is the bioreactivity of vitamin-E-modified dialyzer an expression of increased plasmatic vitamin E concentration?
    Senatore M; Nicoletti A; Rizzuto G
    Nephron; 2002 Oct; 92(2):487-9. PubMed ID: 12218339
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reuse and Biocompatibility of Hemodialysis Membranes: Clinically Relevant?
    Upadhyay A; Jaber BL
    Semin Dial; 2017 Mar; 30(2):121-124. PubMed ID: 28066932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fundamental Characteristics of the Newly Developed ATA™ Membrane Dialyzer.
    Sunohara T; Masuda T
    Contrib Nephrol; 2017; 189():215-221. PubMed ID: 27951571
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Amino acid and albumin losses during hemodialysis.
    Ikizler TA; Flakoll PJ; Parker RA; Hakim RM
    Kidney Int; 1994 Sep; 46(3):830-7. PubMed ID: 7996804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Optimal Time for Recirculation with Ultrafiltration to Remove Disinfectant in Reused Dialyzer.
    Itthipongsakul P; Srimongkol W; Sorthananusak A; Shayakul C
    ASAIO J; 2022 Nov; 68(11):1414-1418. PubMed ID: 36326706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.